ACH (ACH) Stock Analysis

Verdict: AVOID

Severe balance sheet distress with -$461M equity and $2.23B debt makes ACH a high-dilution or restructuring risk despite home health assets.

Investment score: 13/100

The model sees Accendra Health as a distressed medical distributor in critical balance sheet territory. With negative net equity and $2.23B in debt, the risk of capital restructuring dominates the outlook.

View the full interactive analysis